Health · 1 sources covering this

STAT+: Members of Congress push back on plan to create a commission of political appointees to review NIH grants

Several members of Congress voiced strong opposition about a reported plan to create a panel of political appointees to sign off on NIH grants

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·2h ago
STAT+: Members of Congress push back on plan to create a commission of political appointees to review NIH grants
Several members of Congress voiced strong opposition about a reported plan to create a panel of political appointees to sign off on NIH grants
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/b28dbec6c1452907530084d68d1475376cb6610e"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Members of Congress push back on plan to create a commission of political appointees to review NIH grants"></iframe>

STAT+: Members of Congress push back on plan to create a commission of political appointees to review NIH grants

How 1 sources are covering this

STAT+: Members of Congress push back on plan to create a commission of political appointees to review NIH grants

More from Health

STAT+: What a vote on Grail’s cancer detection test could mean for the company, patients, and regulators

STAT+: Lilly’s breast cancer combo wins approval

STAT+: Pharmalittle: We’re reading about Novo plans to expand its pipeline, early Alkermes ADHD data, and more

President Trump’s newest vaccine ‘demands’ repeat old misinformation

Reader

Trust & legal

Across the network

How 1 sources are covering this

STAT+: Members of Congress push back on plan to create a commission of political appointees to review NIH grants

More from Health

STAT+: What a vote on Grail’s cancer detection test could mean for the company, patients, and regulators

STAT+: Lilly&#8217;s breast cancer combo wins approval

STAT+: Pharmalittle: We’re reading about Novo plans to expand its pipeline, early Alkermes ADHD data, and more

President Trump&#8217;s newest vaccine &#8216;demands&#8217; repeat old misinformation

Reader

Trust & legal

Across the network

STAT+: Lilly’s breast cancer combo wins approval

President Trump’s newest vaccine ‘demands’ repeat old misinformation